Random Analytica: AstraZeneca COVID-19 vaccine and cases of Thrombosis with thrombocytopenia syndrome (TTS) by Age Group as at 27 June 2021
by Shane Granger
The Therapeutic Goods Administration (TGA) has updated its latest safety report with no new confirmed deaths reported. Via the TGA. COVID-19 vaccine weekly safety report – 01-07-2021. Summary:
- The most frequently reported suspected side effects associated with Comirnaty (Pfizer) and AstraZeneca COVID-19 vaccines continue to be events that were seen in the clinical trials, and are commonly experienced with vaccines generally.
- Five additional cases of blood clots with low blood platelets have been assessed as thrombosis with thrombocytopenia syndrome (TTS) likely to be linked to the AstraZeneca vaccine. When assessed using the United Kingdom (UK) case definition, two were confirmed and three were deemed probable TTS. This brings the total number of cases of TTS to 69.
To date there have been approximately 4.6-million doses of AstraZeneca administered to 30 June (h/t CovidBaseAU) and two confirmed TTS deaths linked to the AstraZeneca vaccine.
It’s also worth noting that younger people are volunteering to get the AstraZeneca jab after the Prime Minister’s surprise announcement earlier this week. We should see that data flow through to next weeks report.